Skip to content
10-K

Annual Report

VAXXINITY, INC.

0001562762-22-000139

← back to feed
Filed
Mar 24, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Capex FY 2021 · Dec 31, 2020 $1.48M
Operating Cash Flow FY 2021 · Dec 31, 2020 −$33.91M
Cash And Equivalents FY 2021 · Dec 31, 2020 $31.14M
Current Liabilities FY 2021 · Dec 31, 2020 $39.36M
Total Liabilities FY 2021 · Dec 31, 2020 $75.04M
Current Assets FY 2021 · Dec 31, 2020 $35.67M
Total Assets FY 2021 · Dec 31, 2020 $50.14M
Sga Expense FY 2021 · Dec 31, 2020 $12.22M
Rd Expense FY 2021 · Dec 31, 2020 $20.57M
Net Income FY 2021 · Dec 31, 2020 −$39.96M
Operating Income FY 2021 · Dec 31, 2020 −$32.28M
Gross Profit FY 2021 · Dec 31, 2020 $505K
Cost Of Revenue FY 2021 · Dec 31, 2020 $52K
Revenue FY 2021 · Dec 31, 2020 $557K
Stockholders Equity FY 2021 · Dec 31, 2019 −$48.51M